Kodiak Sciences Inc reports results for the quarter ended June 30 - Earnings Summary

Kodiak Sciences

13/08/2025 21:13

Kodiak Sciences Inc KOD.OQ reported a quarterly adjusted loss of $1.03​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -86 cents.  The mean expectation of six analysts for the quarter was for a loss of $1.07 per share. Wall Street expected results to range from $-1.15 to -95 cents per share.

Reported revenue was zero​; analysts expected zero.

Kodiak Sciences Inc's reported EPS for the quarter was a loss of $1.03​.

The company reported a quarterly loss of $54.31 million.

Kodiak Sciences Inc shares had risen by 128.4% this quarter and lost 14.4% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 4.5% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and 3 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is  "buy."

Wall Street's median 12-month price target for Kodiak Sciences Inc is $3.50, about 143.4% below its last closing price of $8.52

This summary was machine generated from LSEG data August 13 at 08:13 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
-1.07
-1.03
Beat
Mar. 31 2025
-0.89
-1.09
Missed
Dec. 31 2024
-0.88
-0.84
Beat
Sep. 30 2024
-0.90
-0.84
Beat